Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 31,636 articles published since 2008
|||| 49 

These are the 31636 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
101 Editorial The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology. 2018

Reccia, Isabella / Kumar, Jayant / Habib, Nagy / Sodergren, Mikael. ·Department of Surgery & Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK. isabella.reccia@gmail.com. · Department of Surgery & Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Department of Surgery & Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK. m.sodergren@imperial.ac.uk. ·Med Oncol · Pubmed #30284649.

ABSTRACT: Despite significant improvement in treatment, the prognosis of pancreatic ductal adenocarcinoma remains poor as the biology of the tumour affects survival even when a radical resection has been performed. Pancreatic cancer remains resistant to currently available chemotherapeutic options. Recently, immunotherapy has achieved significant results in certain types of cancer. However, for pancreatic cancer, results were not initially encouraging as pancreatic cancer microenvironment is highly immunosuppressive. Radiofrequency ablation is currently used as treatment option especially for liver cancer with significant results. However, in pancreatic cancer, the use of radiofrequency ablation is relatively new. Radiofrequency ablation has been identified as a promising mechanism to induce antigen-presenting cell infiltration and enhance systemic antitumour T-cell immune response and tumour regression. In this short communication, we briefly review the role of radiofrequency ablation in pancreatic cancer and explore the idea that the combination of radiofrequency ablation with immunotherapy could represent a novel and promising treatment.

102 Editorial Factors Predictive of Malignancy Potency in Pure Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Mural Nodules. 2018

Lee, Tae Hoon. ·Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University School of Medicine, Cheonan, Korea. ·Gut Liver · Pubmed #30205669.

ABSTRACT: -- No abstract --

103 Editorial Harnessing Analytic Morphomics for Early Detection of Pancreatic Cancer. 2018

Petrov, Maxim S. ·From the Department of Surgery, University of Auckland, Auckland, New Zealand. ·Pancreas · Pubmed #30199485.

ABSTRACT: -- No abstract --

104 Editorial Time to think: Selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases. 2018

Shi, Si / Yu, Xian-Jun. ·Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China. ·World J Gastroenterol · Pubmed #30197474.

ABSTRACT: Pancreatic cancer remains a lethal disease and is associated with poor prognosis, particularly for patients with distant metastasis at diagnosis. Recently, Oweira reported a retrospective study that included 13233 metastatic pancreatic cancer patients from the Surveillance, Epidemiology and End Results database. They demonstrated that pancreatic cancer patients with isolated liver metastases had worse outcomes than patients with isolated lung metastases or distant nodal metastases. At present, the standard treatment for metastatic pancreatic cancer is chemotherapy. However, improvement in the safety of pancreatic surgery has led to the consideration of more aggressive surgical approaches. Schneitler reported two cases of hepatic metastatic pancreatic cancer in which negative margin (R0) resection and long survival were achieved after effective preoperative chemotherapy. In general, these two studies indicate that although pancreatic cancer patients with liver metastasis have a poor prognosis, surgical approaches may prolong survival for a few of these patients. A strategy to select hepatic metastatic pancreatic cancer patients who may benefit from surgical intervention is urgently needed.

105 Editorial Dynamic Behavior of Ca 19-9 and Pancreatic Cancer Recurrence: Enough Data to Drive Salvage Therapy? 2018

Malleo, Giuseppe. ·Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy. giuseppe.malleo@aovr.veneto.it. ·Ann Surg Oncol · Pubmed #30128901.

ABSTRACT: -- No abstract --

106 Editorial Gastroenterological Cancer and Immunotherapy. 2018

Wang, Xiaoping / Yang, Yixin Eric / Jia, Lintao / Chen, Qi. ·Department of Pathology, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China. · School of Natural Sciences, College of Natural, Applied and Health Sciences, Kean University, Union, NJ, USA. · Department of Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, China. · Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, KS, USA. ·Can J Gastroenterol Hepatol · Pubmed #30073155.

ABSTRACT: -- No abstract --

107 Editorial Cyst wall brushing. Exploring the limits of cytology. 2018

Martínez Moreno, Belén / Aparicio Tormo, José Ramón. ·Hospital Universitario del Vinalopó. · Hospital General Universitario de Alicante, España. ·Rev Esp Enferm Dig · Pubmed #30032626.

ABSTRACT: With the increasingly widespread use of imaging techniques pancreatic cystic lesions (PCLs) are now commonly identified. Their prevalence among the symptom-free population ranges from 2.4% to 13.5%. However, a recent study by our group revealed PCLs in up to 21.5% of patients undergoing endoscopic ultrasound (EUS) for non-pancreas conditions, an incidence that increases with age. Identifying PCLs in an otherwise asymptomatic population has become a significant clinical issue.

108 Editorial Distal pancreatectomy in the community setting: Application of the Donabedian principles. 2018

Greene, Frederick L. ·Cancer Data Services, Levine Cancer Institute, Charlotte, NC, USA; University of North Carolina School of Medicine, USA. Electronic address: rick_greene@med.unc.edu. ·Surg Oncol · Pubmed #30017174.

ABSTRACT: -- No abstract --

109 Editorial Pancreatic Cancer Chemoprevention: Challenges and Opportunities. 2018

Mohammed, Altaf / Rao, Chinthalapally V. ·Chemopreventive Agent Development Research Group (CADRG) Division of Cancer Prevention National Cancer Institute Rockville, MD 20850, United States. · Center for Cancer Prevention and Drug Development (CCPDD) Stephenson Cancer Center, Medical Oncology University of Oklahoma Health Sciences Center Oklahoma City, OK 73104, United States. ·Curr Med Chem · Pubmed #30014794.

ABSTRACT: -- No abstract --

110 Editorial Sweet Predictions Speak Volumes for Early Detection of Pancreatic Cancer. 2018

Soreide, Kjetil. ·Gastrointestinal Translational Research Unit, Stavanger University Hospital, Stavanger, Norway and Clinical Surgery, University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, UK and Clinical Medicine, University of Bergen, Bergen, Norway and Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway. Electronic address: ksoreide@mac.com. ·Gastroenterology · Pubmed #29966611.

ABSTRACT: -- No abstract --

111 Editorial Germline Genetic Testing for Pancreatic Ductal Adenocarcinoma at Time of Diagnosis. 2018

Syngal, Sapna / Furniss, C Sloane. ·Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts. ·JAMA · Pubmed #29922810.

ABSTRACT: -- No abstract --

112 Editorial Unmasking Pancreatic Cancer: Epitope Spreading After Single Antigen Chimeric Antigen Receptor T-Cell Therapy in a Human Phase I Trial. 2018

Heckler, Max / Dougan, Stephanie K. ·Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Electronic address: Stephanie_Dougan@dfci.harvard.edu. ·Gastroenterology · Pubmed #29885301.

ABSTRACT: -- No abstract --

113 Editorial CT and MRI of pancreatic cancer: there is no rose without a thorn! 2018

Kartalis, N. ·Division of Radiology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden. nikolaos.kartalis@sll.se. · Department of Abdominal Radiology, Karolinska University Hospital, Stockholm, Sweden. nikolaos.kartalis@sll.se. ·Eur Radiol · Pubmed #29796919.

ABSTRACT: -- No abstract --

114 Editorial Pancreatic cancer screening in high-risk individuals: Ready for prime time? 2018

Bruno, Marco J. ·Department of Gastroenterology and Hepatology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands. ·Gastrointest Endosc · Pubmed #29759159.

ABSTRACT: -- No abstract --

115 Editorial EUS-FNA giving way to fine-needle biopsy: Is it time to retire your old trusted needles? 2018

El Hajj, Ihab I / Al-Haddad, Mohammad. ·Division of Gastroenterology and Hepatology, Section of Interventional Endoscopy, Indiana University School of Medicine, Indianapolis, Indiana, USA. ·Gastrointest Endosc · Pubmed #29759158.

ABSTRACT: -- No abstract --

116 Editorial The Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Taking Antithrombotic Agents Is Not Negligible. 2018

Jang, Dong Kee / Lee, Sang Hyub. ·Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea. · Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. ·Gut Liver · Pubmed #29724088.

ABSTRACT: -- No abstract --

117 Editorial Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy. 2018

Cho, Chang Min. ·Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea. ·Gut Liver · Pubmed #29724087.

ABSTRACT: -- No abstract --

118 Editorial Mahvash Disease: 10 Years After Discovery. 2018

Yu, Run. ·From the Division of Endocrinology, Diabetes, and Metabolism, David Geffen School of Medicine at UCLA, Los Angeles, CA. ·Pancreas · Pubmed #29702528.

ABSTRACT: -- No abstract --

119 Editorial What is the Incidence of Malignancy in Resected IPMN? An Analysis of Over 100 U.S. Institutions in a Single Year. 2018

Schmidt, Carl R / Cloyd, Jordan. ·Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. carl.schmidt@osumc.edu. · Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. ·Ann Surg Oncol · Pubmed #29675763.

ABSTRACT: -- No abstract --

120 Editorial Preoperative biliary drainage in pancreatic head cancer patients. 2018

Aljahdli, Emad S. ·Division of Gastroenterology and Hepatology, Department of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia. ·Saudi J Gastroenterol · Pubmed #29652035.

ABSTRACT: -- No abstract --

121 Editorial Management of distal malignant biliary obstruction. 2018

Aljahdli, Emad S. ·Consultant, Division of Gastroenterology, Department of Internal Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia. ·Saudi J Gastroenterol · Pubmed #29637911.

ABSTRACT: -- No abstract --

122 Editorial Novel Mechanism of Cancer Thrombosis Induced by Microvesicles. 2018

McCrae, Keith R. ·From the Taussig Cancer Institute and Department of Cellular and Molecular Medicine, Cleveland Clinic, OH. mccraek@ccf.org. ·Arterioscler Thromb Vasc Biol · Pubmed #29563113.

ABSTRACT: -- No abstract --

123 Editorial PAK4 pathway as a potential therapeutic target in pancreatic cancer. 2018

Thillai, Kiruthikah / Sarker, Debashis / Wells, Claire. ·Cancer Studies, King's College London, London, SE1 9RT, UK. · Department of Medical Oncology, Guy's & St Thomas' NHS Trust, London, SE1 9RT, UK. ·Future Oncol · Pubmed #29508632.

ABSTRACT: -- No abstract --

124 Editorial Early Detection of Pancreatic Cancer: The Role of Depression and Anxiety as a Precursor for Disease. 2018

Kenner, Barbara J. ·From the Kenner Family Research Fund, New York, NY. ·Pancreas · Pubmed #29498966.

ABSTRACT: -- No abstract --

125 Editorial Elucidating the link between collagen and pancreatic cancer: what's next? 2018

Hamada, Shin / Masamune, Atsushi. ·a Division of Gastroenterology , Tohoku University Graduate School of Medicine , Sendai , Japan. ·Expert Rev Gastroenterol Hepatol · Pubmed #29495889.

ABSTRACT: -- No abstract --

Back · Next